2019
DOI: 10.1001/jamasurg.2019.2169
|View full text |Cite
|
Sign up to set email alerts
|

Review of the Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 9 publications
1
12
0
Order By: Relevance
“…Given the development of an increasing amount of antimicrobial resistance ( Buckman and Mazuski, 2019 ), sample cultures and susceptibility tests should be performed as soon as possible for patients with choledocholithiasis, especially those with acute cholangitis. In addition to the decision for antimicrobial usage, this study demonstrated the predictive value of specific microorganisms from bile for patient conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Given the development of an increasing amount of antimicrobial resistance ( Buckman and Mazuski, 2019 ), sample cultures and susceptibility tests should be performed as soon as possible for patients with choledocholithiasis, especially those with acute cholangitis. In addition to the decision for antimicrobial usage, this study demonstrated the predictive value of specific microorganisms from bile for patient conditions.…”
Section: Discussionmentioning
confidence: 99%
“…The emergency admission to the hospital has not shown to be significant in the decision to place surgical drain. Probably, the correct selection of the patient undergoing surgery, in accordance with the 2018 Tokyo Guidelines (28,29), plays a key role. For example, in the case of fragile patients with emergency admission, it is preferable to adopt a conservative treatment with percutaneous drainage and antimicrobial therapy scheduling elective surgery subsequently, reducing the risk to place a drain (30)(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…Recognizing that prompt diagnosis of biliary sepsis and initiation of appropriate antimicrobial therapy and source control are cornerstones in the treatment of acute cholecystitis and biliary pancreatitis, TG18 recommends obtaining blood cultures on admission 14 . However, just 24 per cent of respondents reported following this guideline for cholecystitis and 32 per cent for pancreatitis.…”
Section: Discussionmentioning
confidence: 99%
“…The TG18 expert group 2 proposed a management bundle emphasizing the prompt diagnosis of acute cholecystitis, biliary pancreatitis and cholangitic choledocholithiasis, and early evaluation of surgical risk, with the commencement of appropriate resuscitation and antimicrobial administration. To guide appropriate antimicrobial management based on local antimicrobial susceptibility data, blood and/or bile cultures are strongly recommended in TG18 14 . For definitive treatment of moderate or severe disease presentation, TG18 advocates early cholecystectomy (within 7 days, but preferably within 72 h) and/or biliary drainage where patient factors allow, reserving delayed cholecystectomy for cases in which delayed presentation, negative physiological factors or patient co‐morbidity favoured non‐operative management 2,11,12 .…”
Section: Introductionmentioning
confidence: 99%